Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Science Investments (LSI) is a specialized pharmaceutical company founded in 1999 and headquartered in London, United Kingdom. The company focuses on the development and commercialization of innovative cosmeceuticals and nutraceuticals for dermatology, plastic surgery, and aesthetic medicine. LSI's product portfolio addresses unmet needs in skin conditions such as vitiligo, rosacea, melasma, and scarring, with well-known brands including Vitix, Sodermix, and Biotopix. The company operates manufacturing facilities in Switzerland and France and maintains a global presence in over 70 countries. LSI emphasizes the use of plant-derived active ingredients and backs its products with published clinical evidence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life Science Investments.